Rubfila International Share Price Today

Rubfila International discloses reclassification of 1.28% stake by Bharati Dattani

Reclassified 1.28% stake from Promoter to Public category. Shareholder Mrs. Bharati B Dattani holds 6,95,091 shares. Applications for no-objection filed with NSE and BSE in September 2026.

Rubfila International adopts FY26 accounts, approves divestment in Premier Tissues

Rubfila International adopted FY26 audited financial statements and declared a dividend. Shareholders approved the divestment of entire shareholding in Premier Tissues India Ltd. Hardik B Patel was re-appointed as director after retiring by rotation. The 33rd AGM was held virtually on September 29, 2026, with 44 participants.

Rubfila declares ₹2 per share final dividend for FY26

Rubfila International declared a final dividend of ₹2 per equity share for FY26. Shareholders on record as of September 22, 2026, will be eligible for the payout. The board approved the dividend in its meeting on May 26, 2026. The disclosure complies with SEBI LODR Regulation 42 requirements.

Rubfila International approves promoter re-classification for Dattani

Rubfila International board approved re-classifying Mrs. Bharati Bharat Dattani from promoter to public category. Mrs. Dattani holds 6,95,091 shares, constituting 1.28% of paid-up equity capital. She declared no control over company affairs or representation on the Board. Process requires no-objection from stock exchanges and subsequent shareholder approval. Action taken pursuant to Regulation 31A of SEBI LODR Regulations.

Rubfila International to sell Premier Tissues for ₹61 crore at upcoming AGM

Rubfila International proposes to sell 100% of Premier Tissues India Ltd to related party Finquest Personal Care for ₹61 crore. The deal price of ₹54.26 per share exceeds independent valuations of ₹49.50 and ₹47.93 per share. Standalone revenue grew 9.24% YoY to ₹51,171.86 lakh while standalone PAT rose 6.72% to ₹2,630.13 lakh. Consolidated PAT fell to ₹2,661.19 lakh from ₹2,943.85 lakh due to lower margins in the tissue segment. Statutory auditors issued a qualified opinion regarding a ₹1,349 lakh provision for contingencies.

Rubfila International Q1FY27 net profit up 0.6% to ₹6.0 crore

Rubfila International’s Q1FY27 results show resilient profitability despite a double-digit drop in revenue. Standalone net profit rose marginally to ₹5.99 crore, while consolidated profit fell to ₹5.80 crore. The company maintains a strong balance sheet with a debt-equity ratio below 0.20.